abrdn Healthcare Investors (NYSE:HQH) Reaches New 1-Year High – Still a Buy?

abrdn Healthcare Investors (NYSE:HQH – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $21.91 and last traded at $21.84, with a volume of 75456 shares traded. The stock had previously closed at $21.63.

abrdn Healthcare Investors Stock Up 0.2%

The company has a 50 day moving average of $19.85 and a 200-day moving average of $19.26.

Get abrdn Healthcare Investors alerts:

abrdn Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Thursday, May 21st were given a dividend of $0.61 per share. This represents a $2.44 dividend on an annualized basis and a yield of 11.1%. The ex-dividend date of this dividend was Thursday, May 21st.

Institutional Investors Weigh In On abrdn Healthcare Investors

Several institutional investors and hedge funds have recently modified their holdings of the stock. Concorde Asset Management LLC increased its position in shares of abrdn Healthcare Investors by 6.3% during the first quarter. Concorde Asset Management LLC now owns 11,487 shares of the financial services provider’s stock valued at $204,000 after buying an additional 676 shares during the period. Ashton Thomas Securities LLC grew its holdings in shares of abrdn Healthcare Investors by 6.5% during the 1st quarter. Ashton Thomas Securities LLC now owns 11,592 shares of the financial services provider’s stock worth $206,000 after acquiring an additional 712 shares during the period. Uhlmann Price Securities LLC raised its position in shares of abrdn Healthcare Investors by 3.0% in the 1st quarter. Uhlmann Price Securities LLC now owns 26,490 shares of the financial services provider’s stock worth $471,000 after acquiring an additional 779 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of abrdn Healthcare Investors by 7.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 11,732 shares of the financial services provider’s stock valued at $191,000 after purchasing an additional 788 shares during the period. Finally, NewEdge Advisors LLC boosted its position in shares of abrdn Healthcare Investors by 2.1% during the second quarter. NewEdge Advisors LLC now owns 44,130 shares of the financial services provider’s stock valued at $684,000 after purchasing an additional 897 shares in the last quarter. 32.60% of the stock is owned by hedge funds and other institutional investors.

abrdn Healthcare Investors Company Profile

(Get Free Report)

abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.

The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.

Featured Articles

• Five stocks we like better than abrdn Healthcare Investors
• Burger King’s Turnaround Is Putting Restaurant Brands Back in Focus
• Short Squeeze Alert—Moderna Stock Surges on New Strategy
• NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
• Amazon Could Be About to Reap the Rewards of a Software Spending Boom

Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.